Symptom Prevalence in Spanish and Colombian Oncology Patients Measured with the MSAS.

Cancer patients experience several symptoms throughout their illness and the treatments they receive. While this pathology represents a worldwide health problem, knowing the symptom prevalence in oncology patients remains a challenge; validated tools to obtain this information are essential. Furthermore, this prevalence information would help health professionals to establish appropriate treatments. The objective of this study was to ascertain the symptom prevalence in cancer patients from Spain and Colombia to improve future approaches. The frequency, severity, and distress of 32 symptoms from a validated scale experienced by cancer patients from Spain and Colombia were measured. Two hundred and forty-six patients (49.7%) who attended the Day University Hospital of Salamanca (Spain) and two hundred and forty-nine outpatients (50.3%) of the San Diego Cancer Center (Colombia) between 2016 and 2019 participated in the study. All patients filled in the Assessment Scale only once. Four hundred and ninety-five patients (333 women (67.3%) and 162 men (32.7%)) completed the Memorial Symptom Assessment Scale (Spanish version). The most frequent symptom for both samples (Spanish and Colombian) was "lack of energy" (38.4% and 13.7%, respectively). The most severe symptoms for the Spanish and Colombian samples were "problems with sexual interest or activity" (38.4%) and "dry mouth" (13.7%), respectively, and both samples agreed on the most distressing symptom: "hair loss" (Spanish, 38%; Colombian, 10.1%). The Spanish version of the MSAS has proven to be a valid and reliable tool in Spanish-speaking countries to obtain the most prevalent, severe, and distressing symptoms in Spanish and Colombian oncology patients. The prevalence of symptoms was demonstrated to be similar across both countries, and the results will help to design and adapt treatments for cancer patients, targeting these symptoms to reduce or avoid them and thus improving their quality of life.

Escala de evaluación de síntomas Memorial 10-18: Adaptación cultural y validez para oncología pediátrica Colombia / Memorial symptom assessment scale 10-18: Cultural adaptation and validity for pediatric oncology Colombia

Objetivo principal: Adaptar culturalmente y validar en el componente de validez facial y de contenido la escala de evaluación de síntomas Memorial 10-18 años en pediatría oncológica en Colombia. Metodología: Estudio de validación de escalas en dos fases: 1. Adaptación cultural al contexto colombiano 2. Validación facial y de contenido. Los participantes eran adolescentes sanos y con diagnóstico oncológico entre 10 a 18 años de edad. Resultados principales: Se obtuvo versión adaptada de la MSAS 10-18 al contexto colombiano para escenarios de oncología pediátrica, con comprensibilidad global de ítems mayor al 85 % e índice de validez de contenido de 0.71. Conclusión principal: La escala de evaluación de síntomas Memorial 10-18 años proporciona cumple con propiedades psicométricas para su aplicación en la práctica, contribuyendo a mejorar la calidad de vida al niño con cáncer y su familia.(AU)

Objective: Culturally adapt and validate in the component of facial validity and content the Memorial Symptom Assessment Scale 10-18 years in oncological pediatrics in Colombia. Methods: Scale validation study in two phases: 1. Cultural adaptation of the MSAS 10-18 to the Colombian, 2. Facial and content validation with experts in the phenomenon and children with cancer between the ages described. Participants were healthy adolescents and with oncological diagnosis between 10 and 18 years of age. Results: An adapted version of the Memorial Symptom Assessment Scale 10-18 was obtained for the Colombian context for pediatric oncology scenarios, with an overall comprehensibility of the items greater than 85 % and a content validity index of 0.71. Conclusions: Having specific scales adapted to the age group and the context in which they are applied, provides theoretical and disciplinary knowledge to guide the practice, contributing to improve the quality of life and comprehensive care for children with cancer and their family.(AU)

Evaluación de síntomas en niños y adolescentes con cáncer: revisión integrativa / Evaluation of symptoms in children and adolescents with cancer: comprehensive review / Avaliação dos sintomas em crianças e adolescentes com câncer: uma revisão integrativaJennifer

Los niños y adolescentes diagnosticados con cáncer se enfrentan a una serie de cam-bios en los diferentes aspectos de su vida, y experimentan múltiples síntomas físicos y psicosociales a causa de la enfermedad y su tratamiento, lo que afecta su calidad de vida y la de sus cuidadores. Objetivo: Indagar el estado del aspecto investigativo relacionado con la temática sobre evaluación de síntomas en niños y adolescentes con cáncer. Método: Revisión integrativa de la producción científica generada entre 2007 y 2018 en las bases de datos Embase, Ovid, Medline, Pubmed, Science Direct y Scie-lo en inglés, español y portugués. Se incluyeron 50 artículos que aportan información sobre evaluación de síntomas en población pediátrica con diagnóstico de cáncer. Re-sultados: Las investigaciones sobre herramientas que evalúan la manifestación de síntomas, adaptadas y validadas a población pediátrica son limitadas. Conclusiones: Los niños y adolescentes con cáncer presentan síntomas durante las distintas fases de la enfermedad y el tratamiento. Son escasos los estudios sobre estos síntomas en el contexto local, por tanto se requiere validar escalas específicas para esta población, describir los síntomas incluyendo variables clínicas y de calidad de vida percibidas que sirvan para orientar intervenciones oportunas en el manejo de los mismos.

Children and adolescents diagnosed with cancer face a number of changes in diffe-rent aspects of their lives, and experience multiple physical and psychosocial symp-toms from the disease and its treatment, affecting their quality of life and that of their caregivers. Objective: To investigate the state of the research aspect related to the subject of symptom assessment in children and adolescents with cancer. Methods: Integrative review of the scientific production generated between 2007 and 2018 in the databases Embase, Ovid, Medline, Pubmed, Science Direct and Scielo in English, Spanish and Portuguese. It included 50 articles that provide information on symptom assessment in pediatric population with cancer diagnosis. Results: Research on tools that evaluate the manifestation of symptoms, adapted and validated to paediatric population are limited. Con-clusions: Children and adolescents with cancer present with symptoms during the different stages of the disease and treatment. Studies on these symptoms in the local context are scarce, therefore it is necessary to validate specific scales for this population, to describe the symptoms including clinical variables and perceived quality of life that serve to guide opportune interventions in their management.

As crianças e adolescentes diagnosticadas com câncer enfrentam-se a uma série de mudanças nos diferentes aspectos das suas vidas, experimentam sintomas físicos e psicossociais a causa da doença e o tratamento, afetando a sua qualidade de vida e a dos seus cuidadores. Objetivo: Indagar o estado das pesquisas relacionadas com a temática sobre a avalição dos sintomas de crianças e adolescentes com câncer. Métodos: Revisão integrativa da produção científica gerada entre 2007 e 2018 dispo-nível em recursos bibliográficos na internet como Embase, Ovid, Medline, Pubmed, Science Direct e Scielo em inglês, espanhol e português. Incluíram-se 50 artigos que contribuíram com informação sobre avaliação de sintomas em população pediátrica com diagnostico de câncer Resultados: As investigações sobre as ferramentas que avaliaram manifestações dos sintomas, adaptadas e vali-dadas na população pediátrica são limitadas. Conclusões: As crianças e adolescentes com câncer presentam sintomas durante as diferentes etapas da doença e o tratamento. São poucos os estudos sobre estes sintomas no contexto local, portanto, requerem-se instrumentos validados na população pediátrica, descrevendo os sintomas incluindo variáveis clínicas e de qualidade de vida percebidas que orientem intervenções oportunas para o acompanhamento dos mesmos.

Adaptación cultural y validez de la "Memorial Symptom Assessment Scale (MSAS) 10­18" para Pediatría Oncológica en Colombia / Cultural adaptation and validity of the "Memorial Symptom Assessment Scale (MSAS) 10­18" for Pediatric Oncology in Colombia

Los niños y adolescentes con cáncer se enfrentan a una serie de cambios en su dinámica familiar, actividad social, experimentan síntomas físicos y psicoemocionales como consecuencia de la enfermedad y el tratamiento. La comprensión de la prevalencia y características de los síntomas en niños con cáncer se ha visto obstaculizada por la falta de herramientas de evaluación validadas en esta población. Para los enfermeros de la práctica en oncología pediátrica es determinante reconocer y manejar los síntomas, en tanto que tienen contacto directo con su sujeto de cuidado. Objetivo: Adaptar culturalmente y validar la escala de evaluación de síntomas Memorial para adolescentes entre 10- 18 años de edad en pediatría oncológica en el contexto colombiano en el año 2018. Método: Estudio de validación de escalas que se desarrolló en dos fases; la primera fue la adaptación cultural del MSAS 10-18 al contexto colombiano en donde participaron adolescentes sanos y la segunda fase de validación facial y de contenido con participantes expertos en el fenómeno, adolescentes con cáncer entre las edades descritas. Resultados: Se obtuvo versión adaptada de la Memorial Symptom Assessment Scale 10-18 al contexto colombiano para escenarios de oncología pediátrica, con una comprensibilidad global de los ítems mayores al 85% y un índice de validez de contenido de 0.71.

Children and adolescents with cancer face a series of changes in their family dynamics, social activity, they experience physical and psycho-emotional symptoms as a result of the disease and treatment. Understanding the prevalence and characteristics of symptoms in children with cancer has been hampered by the lack of validated assessment tools in this population. For nurses practice in pediatric oncology, it is crucial to recognize and manage the symptoms, as long as they have direct contact with the patients. Objective: To adapt culturally and validate the Memorial symptom assessment scale for children between 10-18 years of age in pediatric oncology in the Colombian context in 2018. Method: Study of validation scale that was developed in two phases; the first was the cultural adaptation of MSAS 10-18 to the Colombian context and the second phase of facial and content validation with expert in the phenomenon and adolescents with cancer between the ages described. Results: An adapted version of the Memorial Symptom Assessment Scale 10-18 was obtained in the Colombian context for pediatric oncology with a global comprehensibility of the items greater than 85% and a content validity index of 0.71